|
2023
|
Invention
|
Nlrx1 ligands.
Provided are compounds that target the nucleotide-binding oligomerization domain,... |
|
|
G/S
|
Research and development in the field of therapeutics, namely, restoring the immune tolerance for... |
|
|
Invention
|
Plxdc2 ligands.
Provided are compounds that target plexin domain containing 2 (PLXDC2). The comp... |
|
2022
|
Invention
|
Tetrahydropyrazolopyridine-analog ligands of nlrx1 and uses thereof.
Tetrahydropyrazolopyridine-... |
|
|
Invention
|
Tetrahydropyrazolopyridine-analog ligands of nlrx1 and uses thereof. Provided are tetrahydropyraz... |
|
2021
|
Invention
|
Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of s... |
|
|
Invention
|
D]imidazo-2-yl)pyridin-2yl)methanone) as lancl2 modulators. HdHdHdHdd]imidazo-2-yl)pyridine-2-yl)... |
|
|
G/S
|
Biopharmaceutical services, namely, research, identification, development and testing of therapeu... |
|
|
G/S
|
Biopharmaceutical services, namely, research,
identification, development and testing of therape... |
|
|
Invention
|
Lancl ligands. Provided are compounds that target the lanthionine synthetase C-like (LANCL) famil... |
|
|
Invention
|
Substituted imidazoles as plxdc2 ligands. Provided are compounds of Formula Y-Z:
The compounds ... |
|
|
Invention
|
Nlrx1 ligands. Provided are compounds that target the nucleotide-binding oligomerization domain, ... |
|
|
Invention
|
Plxdc2 ligands. Provided are compounds that target plexin domain containing 2 (PLXDC2). The compo... |
|
2020
|
Invention
|
Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same. Provide... |
|
2019
|
G/S
|
Biopharmaceutical services, namely, research, development
and testing of therapeutics for patien... |
|
|
G/S
|
Biopharmaceutical services, namely, research, development and testing of therapeutics for patient... |
|
|
Invention
|
1,3,5-tris(6-methylpyridin-2-yloxy)benzene derivatives and related compounds as nlrx1 ligands for... |
|
|
G/S
|
biopharmaceutical services, namely, research, development and testing of therapeutics for patient... |
|
2018
|
Invention
|
Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith. in vitroin vitr... |
|
|
Invention
|
Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith. Provided are co... |
|
2015
|
Invention
|
Lanthionine synthetase c-like 2-based therapeutics. Provided are compounds that target the lanthi... |
